Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro

BMB Reports

Volumn 41, Issue 4, 2008, Pages 294-299

  Wang, Shu Zhen ^a   Luo, Xue Gang ^a   Shen, Jing ^a   Zou, Jia Ning ^a   Lu, Yun Hua ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Doxycycline; RNA interference; Short hairpin RNA; SMYD3

Indexed keywords

EID: 43249122483     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2008.41.4.294     Document Type: Article

References (27)

1. Jones, P.A. and Laird, P.W. (1999) Cancer epigenetics comes of age. Nat. Genet. 21, 163-167.
2. Feinberg, A.P and Tycko, B. (2004) The history of cancer epigenetics. Nat. Rev. Cancer 4, 143-153.
3. Egger, G., Liang, G., Aparicio, A. and Jones, P.A. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463.
4. Johnstone, R.W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1, 287-299.
5. Adams, A.M., Pratt, S.L. and Stice, S.L. (2005) Knockdown of the Dnmt1s transcript using small interfering RNA in primary murine and bovine fibroblast cells. Mol. Reprod. Dev. 72, 311-319.
6. Peter, W.L. (2005) Cancer epigenetics. Hum. Mol. Genet. 14, R65-R76.
7. Brummelkamp, T.R., Bernards, R. and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
8. Paddison, P.J., Caudy, A.A., Bernstein, E., Hannon, G.J. and Conklin, D.S. (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948-958.
9. Sui, G., Soohoo, C., Affar, B., Gay, F., Shi, Y., Forrester, W.C. and Shi. Y. (2002) A DNA vector based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. 99, 5515-5520.
10. Jinsu, K., Hyukmin K., Yoonsoo L., Kyungbae Y., Sangwon B. and Kyuhyung H. (2006) A simple and economical shortoligonucleotide-based approach to shRNA generation. J. Biochem. Mol. Biol. 40, 617-624.
11. van de Wetering, M., Oving, I., Muncan, V., Pon Fong, M.T., Brantjes, H., van Leenen, D., Holstege, F.C., Brummelkamp, T.R., Agami, R. and Clevers, H. (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609-615.
12. Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F.P., Li, M., Yagyu, R. and Nakamura, Y. (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell. Biol. 6, 731-740.
13. Hamamoto, R., Silva, F.P., Tsuge, M., Nishidate, T., Katagiri, T., Nakamura, Y. and Furukawa, Y. (2006) Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci. 97, 113-118.
14. Xu, J.Y., Chen, L.B., Xu, J.Y., Yang, Z., Wei, H.Y. and Xu, R.H. (2006a) Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2. Ai Zheng 25, 526-532.
15. Xu, J.Y., Chen, L.B., Xu, J.Y., Yang, Z., Wei, H.Y., Xu, R.H. (2006b) Suppression of SMYD3 expression in HepG2 cell by shRNA interference. Zhonghua Gan Zang Bing Za Zhi 14, 105-108.
16. Xu, J.Y., Chen, L.B., Xu, J.Y., Yang, Z., Xu, R.H., Wei, H.Y. (2006c) Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference. Zhonghua Wai Ke Za Zhi. 44, 481-484.
17. Chen, L.B., Xu, J.Y., Yang, Z. and Wang, G.B. (2007) Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration. World J Gastroenterol. 13, 5718-5724.
18. Luo, X.G., Ding, Y., Zhou, Q.F., Ye, L., Wang, S.Z. and Xi, T. (2007) SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells. J. Biosci. Bioeng. 103, 444-450.
19. Yao, F., Svensjo, T., Winkler, T., Lu, M., Eriksson, C. and Eriksson, E. (1998) Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum. Gene. Ther. 9, 1939-1950.
20. Wiznerowicz, M., Szulc, J. and Trono, D. (2006) Tuning silence: conditional systems for RNA interference. Nat. Methods 3, 682-688.
21. Matsukura, S., Jones, P.A. and Takai, D. (2003) Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic. Acids. Res. 31, e77.
22. Matthess, Y., Kappel, S., Spankuch, B., Zimmer, B., Kaufmann, M. and Strebhardt, K. (2005) Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1. Oncogene 24, 2973-2980.
23. Szulc, J., Wiznerowicz, M., Sauvain, M.O., Trono, D. and Aebischer, P. (2006) A versatile tool for conditional gene expression and knockdown. Nat. Methods 3, 109-116.
24. Chen, Y., Stamatoyannopoulos, G. and Song, C.Z. (2003) Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 63, 4801-4804.
25. Gupta, S., Schoer, R.A., Egan, J.E., Hannon, G.J. and Mittal, V. (2004) Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 101, 1927-1932.
26. Sims, R.J. and Reinberg, D. (2004) From chromatin to cancer: a new histone lysine methyltransferase enters the mix. Nat. Cell. Biol. 6, 685-687.
27. Hauck, C.R., Hsia, D.A., Puente, X.S., Cheresh, D.A. and Schlaepfer, D.D. (2002) FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. 21, 6289-6302.